摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(5-chloro-8-hydroxyquinolin-7-yl)thiophen-2-ylmethyl]-3-phenylpropanamide

中文名称
——
中文别名
——
英文名称
N-[(5-chloro-8-hydroxyquinolin-7-yl)thiophen-2-ylmethyl]-3-phenylpropanamide
英文别名
N-[(5-chloro-8-hydroxyquinolin-7-yl)(2-thienyl)methyl]-3-phenylpropanamide;N-[(5-chloro-8-hydroxy-7-quinolyl)-(2-thienyl)methyl]-3-phenyl-propanamide;N-[(5-chloro-8-hydroxyquinolin-7-yl)-thiophen-2-ylmethyl]-3-phenylpropanamide
N-[(5-chloro-8-hydroxyquinolin-7-yl)thiophen-2-ylmethyl]-3-phenylpropanamide化学式
CAS
——
化学式
C23H19ClN2O2S
mdl
——
分子量
422.935
InChiKey
SRLJNSQTNHJWPA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    90.5
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    参考文献:
    名称:
    Small molecule activators of mitochondrial function
    摘要:
    通过暴露细胞或治疗受试者以一般公式化合物或组合物,描述了改善线粒体功能、减少铁积累和/或减少氧化应激的方法,这些方法有益于治疗例如弗里德雷希共济失调、正常衰老以及各种神经退行性疾病如阿尔茨海默病和帕金森病等疾病。此外,这些化合物可用作探针,用于识别线粒体代谢缺陷、线粒体铁积累、细胞应激以及其他线粒体疾病,并有助于识别能够克服这些缺陷的活性化合物。
    公开号:
    US09695157B2
点击查看最新优质反应信息

文献信息

  • SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION
    申请人:Wilson Robert B.
    公开号:US20120041023A1
    公开(公告)日:2012-02-16
    Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula (I) are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.
  • US9000009B2
    申请人:——
    公开号:US9000009B2
    公开(公告)日:2015-04-07
  • US9695157B2
    申请人:——
    公开号:US9695157B2
    公开(公告)日:2017-07-04
  • [EN] SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION<br/>[FR] ACTIVATEURS DE PETITES MOLÉCULES DE LA FONCTION MITOCHONDRIALE
    申请人:UNIV PENNSYLVANIA
    公开号:WO2010068767A1
    公开(公告)日:2010-06-17
    Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula (I) are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.
  • Small molecule activators of mitochondrial function
    申请人:THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    公开号:US09695157B2
    公开(公告)日:2017-07-04
    Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.
    通过暴露细胞或治疗受试者以一般公式化合物或组合物,描述了改善线粒体功能、减少铁积累和/或减少氧化应激的方法,这些方法有益于治疗例如弗里德雷希共济失调、正常衰老以及各种神经退行性疾病如阿尔茨海默病和帕金森病等疾病。此外,这些化合物可用作探针,用于识别线粒体代谢缺陷、线粒体铁积累、细胞应激以及其他线粒体疾病,并有助于识别能够克服这些缺陷的活性化合物。
查看更多